These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 29078029)

  • 21. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
    Pagano G; De Micco R; Yousaf T; Wilson H; Chandra A; Politis M
    Neurology; 2018 Sep; 91(10):e894-e905. PubMed ID: 30089615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships of drooling with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.
    Mito Y; Yabe I; Yaguchi H; Sato C; Takei T; Terae S; Tajima Y
    Clin Neurol Neurosurg; 2020 Aug; 195():105951. PubMed ID: 32492588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of patients with longstanding idiopathic REM sleep behavior disorder.
    Iranzo A; Stefani A; Serradell M; Martí MJ; Lomeña F; Mahlknecht P; Stockner H; Gaig C; Fernández-Arcos A; Poewe W; Tolosa E; Högl B; Santamaria J;
    Neurology; 2017 Jul; 89(3):242-248. PubMed ID: 28615430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments.
    Rahmim A; Salimpour Y; Jain S; Blinder SA; Klyuzhin IS; Smith GS; Mari Z; Sossi V
    Neuroimage Clin; 2016; 12():e1-e9. PubMed ID: 27995072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures.
    Chahine LM; Siderowf A; Barnes J; Seedorff N; Caspell-Garcia C; Simuni T; Coffey CS; Galasko D; Mollenhauer B; Arnedo V; Daegele N; Frasier M; Tanner C; Kieburtz K; Marek K;
    J Parkinsons Dis; 2019; 9(4):665-679. PubMed ID: 31450510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of the substantia nigra echogenicity and
    Mašková J; Školoudík D; Štofaniková P; Ibarburu V; Kemlink D; Zogala D; Trnka J; Krupička R; Šonka K; Růžička E; Dušek P
    Sleep Med; 2020 Jun; 70():116-123. PubMed ID: 32403038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid eye movement sleep behaviour disorder and striatal dopamine depletion in patients with Parkinson's disease.
    Chung SJ; Lee Y; Lee JJ; Lee PH; Sohn YH
    Eur J Neurol; 2017 Oct; 24(10):1314-1319. PubMed ID: 28782870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
    Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
    Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder.
    Dušek P; Ibarburu VLYL; Bezdicek O; Dall'antonia I; Dostálová S; Kovalská P; Krupička R; Nepožitek J; Nikolai T; Novotný M; Peřinová P; Rusz J; Serranová T; Tykalová T; Ulmanová O; Mecková Z; Ptáčník V; Trnka J; Zogala D; Růžička E; Šonka K
    Sci Rep; 2019 Oct; 9(1):15463. PubMed ID: 31664065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease.
    Scherfler C; Seppi K; Mair KJ; Donnemiller E; Virgolini I; Wenning GK; Poewe W
    Brain; 2012 Nov; 135(Pt 11):3348-54. PubMed ID: 23043142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
    Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
    Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive loss of raphe nuclei serotonin transporter in early Parkinson's disease: A longitudinal
    Pasquini J; Ceravolo R; Brooks DJ; Bonuccelli U; Pavese N
    Parkinsonism Relat Disord; 2020 Aug; 77():170-175. PubMed ID: 30981664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy.
    Varrone A; Marek KL; Jennings D; Innis RB; Seibyl JP
    Mov Disord; 2001 Nov; 16(6):1023-32. PubMed ID: 11748733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease.
    Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R
    Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder.
    Shin JH; Lee JY; Kim YK; Shin SA; Kim H; Nam H; Jeon B
    Neurology; 2020 Dec; 95(23):e3081-e3092. PubMed ID: 32989104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease.
    Gigante AF; Asabella AN; Iliceto G; Martino T; Ferrari C; Defazio G; Rubini G
    Neurol Sci; 2018 Mar; 39(3):551-555. PubMed ID: 29362953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical REM sleep behavior disorder and motor subtypes in Parkinson's disease: a questionnaire-based study.
    Aygun D; Turkel Y; Onar MK; Sunter T
    Clin Neurol Neurosurg; 2014 Apr; 119():54-8. PubMed ID: 24635926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.
    Simuni T; Caspell-Garcia C; Coffey CS; Weintraub D; Mollenhauer B; Lasch S; Tanner CM; Jennings D; Kieburtz K; Chahine LM; Marek K
    J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):78-88. PubMed ID: 28986467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Syndrome of rapid eye movement sleep behavior disorder and nocturia in Parkinson's disease].
    Nodel MR; Ukraintseva YV; Yakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):15-20. PubMed ID: 29053115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.